Exact Mass: 469.2147496
Exact Mass Matches: 469.2147496
Found 500 metabolites which its exact mass value is equals to given mass value 469.2147496
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nefazodone
Nefazodone hydrochloride (trade name Serzone) is an antidepressant drug marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries, due to the small possibility of hepatic (liver) injury, which could lead to the need for a liver transplant, or even death. The incidence of severe liver damage is approximately 1 in 250,000 to 300,000 patient-years. On May 20, 2004, Bristol-Myers Squibb discontinued the sale of Serzone in the United States. [Wikipedia] D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Nefazodone is an orally active phenylpiperazine antidepressant. Nefazodone can potently and selectively block postsynaptic 5-HT2A receptors, and moderately inhibit 5-HT and noradrenaline reuptake. Nefazodone can also relieve the adverse effects of stress on the the immune system of mice. Nefazodone has a high affinity for CYP3A4 isoenzyme, which indicates that it has certain risk of agent-agent interaction. Nefazodone. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=83366-66-9 (retrieved 2024-10-16) (CAS RN: 83366-66-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
20-COOH-leukotriene E4
C23H35NO7S (469.21341200000006)
20-COOH-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 20-COOH-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)
(-)-N-(2-((R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino)ethyl)-4-fluorobenzamide
Dactolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-Methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide
H-Asp-ala-his-lys-OH
Nitropravastatin
Nitro (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
latrunculol B
C23H35NO7S (469.21341200000006)
A natural product found in Cacospongia mycofijiensis.
His Asn Ala Glu
C18H27N7O8 (469.19210219999997)
Ala Lys His Asp
Asn Ala His Glu
C18H27N7O8 (469.19210219999997)
Gln Ala His Asp
C18H27N7O8 (469.19210219999997)
nefazodone
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Nefazodone is an orally active phenylpiperazine antidepressant. Nefazodone can potently and selectively block postsynaptic 5-HT2A receptors, and moderately inhibit 5-HT and noradrenaline reuptake. Nefazodone can also relieve the adverse effects of stress on the the immune system of mice. Nefazodone has a high affinity for CYP3A4 isoenzyme, which indicates that it has certain risk of agent-agent interaction[1][2][3].
Ala Asp His Lys
Ala Asp His Gln
C18H27N7O8 (469.19210219999997)
Ala Asp Lys His
Ala Asp Gln His
C18H27N7O8 (469.19210219999997)
Ala Glu His Asn
C18H27N7O8 (469.19210219999997)
Ala Glu Asn His
C18H27N7O8 (469.19210219999997)
Ala Gly His Trp
C22H27N7O5 (469.20735720000005)
Ala Gly Trp His
C22H27N7O5 (469.20735720000005)
Ala His Asp Lys
Ala His Asp Gln
C18H27N7O8 (469.19210219999997)
Ala His Glu Asn
C18H27N7O8 (469.19210219999997)
Ala His Gly Trp
C22H27N7O5 (469.20735720000005)
Ala His Lys Asp
Ala His Asn Glu
C18H27N7O8 (469.19210219999997)
Ala His Gln Asp
C18H27N7O8 (469.19210219999997)
Ala His Arg Ser
Ala His Ser Arg
Ala His Trp Gly
C22H27N7O5 (469.20735720000005)
Ala Lys Asp His
Ala Asn Glu His
C18H27N7O8 (469.19210219999997)
Ala Asn His Glu
C18H27N7O8 (469.19210219999997)
Ala Pro Pro Trp
Ala Pro Trp Pro
Ala Gln Asp His
C18H27N7O8 (469.19210219999997)
Ala Gln His Asp
C18H27N7O8 (469.19210219999997)
Ala Arg His Ser
Ala Arg Ser His
Ala Ser His Arg
Ala Ser Arg His
Ala Trp Gly His
C22H27N7O5 (469.20735720000005)
Ala Trp His Gly
C22H27N7O5 (469.20735720000005)
Ala Trp Pro Pro
Cys Gly Lys Tyr
C20H31N5O6S (469.19949460000004)
Cys Gly Tyr Lys
C20H31N5O6S (469.19949460000004)
Cys Lys Gly Tyr
C20H31N5O6S (469.19949460000004)
Cys Lys Tyr Gly
C20H31N5O6S (469.19949460000004)
Cys Tyr Gly Lys
C20H31N5O6S (469.19949460000004)
Cys Tyr Lys Gly
C20H31N5O6S (469.19949460000004)
Asp Ala His Lys
Asp Ala His Gln
C18H27N7O8 (469.19210219999997)
Asp Ala Lys His
Asp Ala Gln His
C18H27N7O8 (469.19210219999997)
Asp His Ala Lys
Asp His Ala Gln
C18H27N7O8 (469.19210219999997)
Asp His Lys Ala
Asp His Gln Ala
C18H27N7O8 (469.19210219999997)
Asp Lys Ala His
Asp Lys His Ala
Asp Gln Ala His
C18H27N7O8 (469.19210219999997)
Asp Gln His Ala
C18H27N7O8 (469.19210219999997)
Glu Ala His Asn
C18H27N7O8 (469.19210219999997)
Glu Ala Asn His
C18H27N7O8 (469.19210219999997)
Glu Gly His Lys
Glu Gly His Gln
C18H27N7O8 (469.19210219999997)
Glu Gly Lys His
Glu Gly Gln His
C18H27N7O8 (469.19210219999997)
Glu His Ala Asn
C18H27N7O8 (469.19210219999997)
Glu His Gly Lys
Glu His Gly Gln
C18H27N7O8 (469.19210219999997)
Glu His Lys Gly
Glu His Asn Ala
C18H27N7O8 (469.19210219999997)
Glu His Gln Gly
C18H27N7O8 (469.19210219999997)
Glu Lys Gly His
Glu Lys His Gly
Glu Asn Ala His
C18H27N7O8 (469.19210219999997)
Glu Asn His Ala
C18H27N7O8 (469.19210219999997)
Glu Pro Pro Gln
Glu Pro Gln Pro
Glu Gln Gly His
C18H27N7O8 (469.19210219999997)
Glu Gln His Gly
C18H27N7O8 (469.19210219999997)
Glu Gln Pro Pro
Gly Ala His Trp
C22H27N7O5 (469.20735720000005)
Gly Ala Trp His
C22H27N7O5 (469.20735720000005)
Gly Cys Lys Tyr
C20H31N5O6S (469.19949460000004)
Gly Cys Tyr Lys
C20H31N5O6S (469.19949460000004)
Gly Glu His Lys
Gly Glu His Gln
C18H27N7O8 (469.19210219999997)
Gly Glu Lys His
Gly Glu Gln His
C18H27N7O8 (469.19210219999997)
Gly His Ala Trp
C22H27N7O5 (469.20735720000005)
Gly His Glu Lys
Gly His Glu Gln
C18H27N7O8 (469.19210219999997)
Gly His Lys Glu
Gly His Gln Glu
C18H27N7O8 (469.19210219999997)
Gly His Arg Thr
Gly His Thr Arg
Gly His Trp Ala
C22H27N7O5 (469.20735720000005)
Gly Lys Cys Tyr
C20H31N5O6S (469.19949460000004)
Gly Lys Glu His
Gly Lys His Glu
Gly Lys Tyr Cys
C20H31N5O6S (469.19949460000004)
Gly Gln Glu His
C18H27N7O8 (469.19210219999997)
Gly Gln His Glu
C18H27N7O8 (469.19210219999997)
Gly Arg His Thr
Gly Arg Thr His
Gly Thr His Arg
Gly Thr Arg His
Gly Trp Ala His
C22H27N7O5 (469.20735720000005)
Gly Trp His Ala
C22H27N7O5 (469.20735720000005)
Gly Tyr Cys Lys
C20H31N5O6S (469.19949460000004)
Gly Tyr Lys Cys
C20H31N5O6S (469.19949460000004)
His Ala Asp Lys
His Ala Asp Gln
C18H27N7O8 (469.19210219999997)
His Ala Glu Asn
C18H27N7O8 (469.19210219999997)
His Ala Gly Trp
C22H27N7O5 (469.20735720000005)
His Ala Lys Asp
His Ala Asn Glu
C18H27N7O8 (469.19210219999997)
His Ala Gln Asp
C18H27N7O8 (469.19210219999997)
His Ala Arg Ser
His Ala Ser Arg
His Ala Trp Gly
C22H27N7O5 (469.20735720000005)
His Asp Ala Lys
His Asp Ala Gln
C18H27N7O8 (469.19210219999997)
His Asp Lys Ala
His Asp Gln Ala
C18H27N7O8 (469.19210219999997)
His Glu Ala Asn
C18H27N7O8 (469.19210219999997)
His Glu Gly Lys
His Glu Gly Gln
C18H27N7O8 (469.19210219999997)
His Glu Lys Gly
His Glu Asn Ala
C18H27N7O8 (469.19210219999997)
His Glu Gln Gly
C18H27N7O8 (469.19210219999997)
His Gly Ala Trp
C22H27N7O5 (469.20735720000005)
His Gly Glu Lys
His Gly Glu Gln
C18H27N7O8 (469.19210219999997)
His Gly Lys Glu
His Gly Gln Glu
C18H27N7O8 (469.19210219999997)
His Gly Arg Thr
His Gly Thr Arg
His Gly Trp Ala
C22H27N7O5 (469.20735720000005)
His Ile Asn Ser
His Ile Ser Asn
His Lys Ala Asp
His Lys Asp Ala
His Lys Glu Gly
His Lys Gly Glu
His Leu Asn Ser
His Leu Ser Asn
His Asn Glu Ala
C18H27N7O8 (469.19210219999997)
His Asn Ile Ser
His Asn Leu Ser
His Asn Ser Ile
His Asn Ser Leu
His Asn Thr Val
His Asn Val Thr
His Gln Ala Asp
C18H27N7O8 (469.19210219999997)
His Gln Asp Ala
C18H27N7O8 (469.19210219999997)
His Gln Glu Gly
C18H27N7O8 (469.19210219999997)
His Gln Gly Glu
C18H27N7O8 (469.19210219999997)
His Gln Ser Val
His Gln Val Ser
His Arg Ala Ser
His Arg Gly Thr
His Arg Ser Ala
His Arg Thr Gly
His Ser Ala Arg
His Ser Ile Asn
His Ser Leu Asn
His Ser Asn Ile
His Ser Asn Leu
His Ser Gln Val
His Ser Arg Ala
His Ser Val Gln
His Thr Gly Arg
His Thr Asn Val
His Thr Arg Gly
His Thr Val Asn
His Val Asn Thr
His Val Gln Ser
His Val Ser Gln
His Val Thr Asn
His Trp Ala Gly
C22H27N7O5 (469.20735720000005)
His Trp Gly Ala
C22H27N7O5 (469.20735720000005)
Ile His Asn Ser
Ile His Ser Asn
Ile Asn His Ser
Ile Asn Ser His
Ile Ser His Asn
Ile Ser Asn His
Lys Ala Asp His
Lys Ala His Asp
Lys Cys Gly Tyr
C20H31N5O6S (469.19949460000004)
Lys Cys Tyr Gly
C20H31N5O6S (469.19949460000004)
Lys Asp Ala His
Lys Asp His Ala
Lys Glu Gly His
Lys Glu His Gly
Lys Gly Cys Tyr
C20H31N5O6S (469.19949460000004)
Lys Gly Glu His
Lys Gly His Glu
Lys Gly Tyr Cys
C20H31N5O6S (469.19949460000004)
Lys His Ala Asp
Lys His Asp Ala
Lys His Glu Gly
Lys His Gly Glu
Lys Tyr Cys Gly
C20H31N5O6S (469.19949460000004)
Lys Tyr Gly Cys
C20H31N5O6S (469.19949460000004)
Leu His Asn Ser
Leu His Ser Asn
Leu Asn His Ser
Leu Asn Ser His
Leu Ser His Asn
Leu Ser Asn His
Asn Ala Glu His
C18H27N7O8 (469.19210219999997)
Asn Glu Ala His
C18H27N7O8 (469.19210219999997)
Asn Glu His Ala
C18H27N7O8 (469.19210219999997)
Asn His Ala Glu
C18H27N7O8 (469.19210219999997)
Asn His Glu Ala
C18H27N7O8 (469.19210219999997)
Asn His Ile Ser
Asn His Leu Ser
Asn His Ser Ile
Asn His Ser Leu
Asn His Thr Val
Asn His Val Thr
Asn Ile His Ser
Asn Ile Ser His
Asn Leu His Ser
Asn Leu Ser His
Asn Ser His Ile
Asn Ser His Leu
Asn Ser Ile His
Asn Ser Leu His
Asn Thr His Val
Asn Thr Val His
Asn Val His Thr
Asn Val Thr His
Pro Ala Pro Trp
Pro Ala Trp Pro
Pro Glu Pro Gln
Pro Glu Gln Pro
Pro Pro Ala Trp
Pro Pro Glu Gln
Pro Pro Gln Glu
Pro Pro Trp Ala
Pro Gln Glu Pro
Pro Gln Pro Glu
Pro Trp Ala Pro
Pro Trp Pro Ala
Gln Ala Asp His
C18H27N7O8 (469.19210219999997)
Gln Asp Ala His
C18H27N7O8 (469.19210219999997)
Gln Asp His Ala
C18H27N7O8 (469.19210219999997)
Gln Glu Gly His
C18H27N7O8 (469.19210219999997)
Gln Glu His Gly
C18H27N7O8 (469.19210219999997)
Gln Glu Pro Pro
Gln Gly Glu His
C18H27N7O8 (469.19210219999997)
Gln Gly His Glu
C18H27N7O8 (469.19210219999997)
Gln His Ala Asp
C18H27N7O8 (469.19210219999997)
Gln His Asp Ala
C18H27N7O8 (469.19210219999997)
Gln His Glu Gly
C18H27N7O8 (469.19210219999997)
Gln His Gly Glu
C18H27N7O8 (469.19210219999997)
Gln His Ser Val
Gln His Val Ser
Gln Pro Glu Pro
Gln Pro Pro Glu
Gln Ser His Val
Gln Ser Val His
Gln Val His Ser
Gln Val Ser His
Arg Ala His Ser
Arg Ala Ser His
Arg Gly His Thr
Arg Gly Thr His
Arg His Ala Ser
Arg His Gly Thr
Arg His Ser Ala
Arg His Thr Gly
Arg Ser Ala His
Arg Ser His Ala
Arg Thr Gly His
Arg Thr His Gly
Ser Ala His Arg
Ser Ala Arg His
Ser His Ala Arg
Ser His Ile Asn
Ser His Leu Asn
Ser His Asn Ile
Ser His Asn Leu
Ser His Gln Val
Ser His Arg Ala
Ser His Val Gln
Ser Ile His Asn
Ser Ile Asn His
Ser Leu His Asn
Ser Leu Asn His
Ser Asn His Ile
Ser Asn His Leu
Ser Asn Ile His
Ser Asn Leu His
Ser Gln His Val
Ser Gln Val His
Ser Arg Ala His
Ser Arg His Ala
Ser Val His Gln
Ser Val Gln His
Thr Gly His Arg
Thr Gly Arg His
Thr His Gly Arg
Thr His Asn Val
Thr His Arg Gly
Thr His Val Asn
Thr Asn His Val
Thr Asn Val His
Thr Arg Gly His
Thr Arg His Gly
Thr Val His Asn
Thr Val Asn His
Val His Asn Thr
Val His Gln Ser
Val His Ser Gln
Val His Thr Asn
Val Asn His Thr
Val Asn Thr His
Val Gln His Ser
Val Gln Ser His
Val Ser His Gln
Val Ser Gln His
Val Thr His Asn
Val Thr Asn His
Trp Ala Gly His
C22H27N7O5 (469.20735720000005)
Trp Ala His Gly
C22H27N7O5 (469.20735720000005)
Trp Ala Pro Pro
Trp Gly Ala His
C22H27N7O5 (469.20735720000005)
Trp Gly His Ala
C22H27N7O5 (469.20735720000005)
Trp His Ala Gly
C22H27N7O5 (469.20735720000005)
Trp His Gly Ala
C22H27N7O5 (469.20735720000005)
Trp Pro Ala Pro
Trp Pro Pro Ala
Tyr Cys Gly Lys
C20H31N5O6S (469.19949460000004)
Tyr Cys Lys Gly
C20H31N5O6S (469.19949460000004)
Tyr Gly Cys Lys
C20H31N5O6S (469.19949460000004)
Tyr Gly Lys Cys
C20H31N5O6S (469.19949460000004)
Tyr Lys Cys Gly
C20H31N5O6S (469.19949460000004)
Tyr Lys Gly Cys
C20H31N5O6S (469.19949460000004)
NVP-BEZ235
20-COOH-leukotriene E4
C23H35NO7S (469.21341200000006)
20-carboxy-LTE4
C23H35NO7S (469.21341200000006)
CP-724714
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor
ethenyl acetate,1-ethenylpyrrolidin-2-one,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid
dimenhydrinate
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Dimenhydrinate is an orally active H1-antihistamine consisting of Diphenhydramine (HY-B0303) and 8-Chlorotheophylline. Dimenhydrinate is used to prevent nausea, vomiting, dizziness, and vertigo associated with motion sickness[1].
Almotriptan
C21H31N3O7S (469.18826160000003)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Almotriptan Malate is a 5-HT1B/1D-receptor agonist used to treat migraine. IC50: Target: 5-hydroxytryptamine1B/1D (5-HT1B/1D) Receptor Almotriptan Malate is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, used for the treatment of Migraine attacks in adults. Almotriptan showed low nanomolar affinity for the 5-HT(1B) and 5-HT(1D) receptors in several species, including the human, while affinity for 5-HT receptors other than 5-HT(1B/1D) was clearly less. Almotriptan did not exhibit significant affinity for several non-5-HT receptors studied up to 100 microM. Almotriptan inhibited forskolin-stimulated cyclic AMP accumulation in HeLa cells transfected with 5-HT(1B) or 5-HT(1D) human receptors [1]. Almotriptan had a mild antiemetic effect and a slight, transient diuretic effect in dogs, although the latter effect is probably of no clinical relevance. In addition, no effect on the respiratory system of conscious guinea pigs was observed following almotriptan treatment. These results indicate that almotriptan has a favourable safety profile with respect to the central nervous, renal and respiratory systems [2].
methysergide
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
5-TBDMS-Bz-dA
5'-O-TBDMS-Bz-dA is a nucleoside with protective and modification effects.
4H-1,2,4-Triazole, 3-(4-(3-(ethylsulfonyl)propyl)bicyclo(2.2.2)oct-1-yl)-4-methyl-5-(2-(trifluoromethyl)phenyl)-
C23H30F3N3O2S (469.20107160000003)
(2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(3-methoxypropyl)-1,4-benzoxazin-3-one
Dactolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(6Z,9Z,11E,13E,15R,16S)-15-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-16-hydroxyicosa-6,9,11,13-tetraenedioic acid
C23H35NO7S (469.21341200000006)
(-)-N-(2-((R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino)ethyl)-4-fluorobenzamide
(2R,3R,4S,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(1-hydroxyethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol
C18H35N3O11 (469.22714800000006)
3,5-Dihydroxy-7-[6-hydroxy-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-2-nitroheptanoic acid
Nitro (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
1-(1-tert-butyl-5-tetrazolyl)-N-(2-furanylmethyl)-N-(phenylmethyl)-1-[4-(trifluoromethyl)phenyl]methanamine
C25H26F3N5O (469.20893420000004)
4-[3-oxo-1-(3,4,5-trimethoxyanilino)-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester
2-{2-oxo-2-[4-(2,3,4-trimethoxybenzyl)piperazin-1-yl]ethyl}-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3-dione
2-[(2R,4aR,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
1-[(2R,3R,6R)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-(3-chlorophenyl)urea
2-[(2S,4aR,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
N-[(2R,4aS,12aR)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[(2S,4aR,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-N-[(3,5-difluorophenyl)methyl]-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyrazinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyrazine-2-carbonyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
1-[(2S,3R,6S)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-(3-chlorophenyl)urea
1-[(2R,3S,6R)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-(3-chlorophenyl)urea
2-[(2R,4aR,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
N-[(2S,4aS,12aR)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[(2S,4aR,12aR)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[(2R,4aR,12aR)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[(2R,4aS,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[[(2S,3R)-8-(3-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(2R,3R)-8-(3-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(2S,3S)-8-(3-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclobutanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyrazinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(5S,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
1-(3-chlorophenyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
2-[(1R,3R,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1R,3S,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1R,3R,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1S,3R,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(2S,4aS,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
2-[(2S,4aS,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
2-[(2R,4aS,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
N-[(2S,4aS,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
(3S)-2-tert-butylsulfinyl-4-[3-[3-(dimethylamino)prop-1-ynyl]phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid
C25H31N3O4S (469.20351660000006)
[(1R)-7-methoxy-9-methyl-1-(3-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
N-[[(2R,3S)-8-(3-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(2S,3S)-8-(3-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(2S,3R)-8-(3-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(2R,3S)-8-(3-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclobutanecarboxamide
N-[[(2R,3R)-8-(3-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclobutanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyrazinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyrazinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyrazinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyrazinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyrazinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
1-(3-chlorophenyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
2-[(1S,3S,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1S,3R,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1S,3S,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1R,3S,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
(3S)-4-[3-(1-cyclohexenyl)phenyl]-3-(2-hydroxyethyl)-N,N-dimethyl-2-methylsulfonyl-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C25H31N3O4S (469.20351660000006)
2-[(2R,4aS,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
2-[(2S,4aR,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
N-[(2R,4aR,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-N-[(3,5-difluorophenyl)methyl]-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(1S)-7-methoxy-2-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
[(1R)-7-methoxy-2-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(2-thiazolylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(2-thiazolylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
[(1S)-7-methoxy-9-methyl-1-(3-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
[(1S)-7-methoxy-9-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
2-Amino-3-[(2-heptanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
C19H36NO10P (469.2076726000001)
2-Amino-3-[hydroxy-(2-octanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxypropanoic acid
C19H36NO10P (469.2076726000001)
2-Amino-3-[(3-butanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
C19H36NO10P (469.2076726000001)
2-Amino-3-[(2-decanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
C19H36NO10P (469.2076726000001)
3-[(3-Acetyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
C19H36NO10P (469.2076726000001)
methysergide
C21H27N3O2.C4H4O4 (469.2212746)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
20-carboxyleukotriene E4
C23H35NO7S (469.21341200000006)
A leukotriene that is leukotriene E4 in which the terminal methyl grop has been oxidised to the corresponding carboxylic acid.
N(1),N(8)-bis(caffeoyl)spermidine
A secondary amino compound that is spermidine in which each of the primary amino groups has been mono-acylated by formal condensation with trans-caffeic acid.
(2s)-2-{[(3r)-3-amino-6-{[(1s)-1-carboxy-2-phenylethyl]-c-hydroxycarbonimidoyl}-1-hydroxyhexylidene]amino}-3-phenylpropanoic acid
(1s,2r,3s,4r,4ar,8as)-2,3-dihydroxy-3,4,8,8a-tetramethyl-4-[(2s)-6-oxo-2h,3h,4h-furo[2,3-c]furan-2-yl]-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl pyridine-3-carboxylate
2-({3-amino-6-[(1-carboxy-2-phenylethyl)-c-hydroxycarbonimidoyl]-1-hydroxyhexylidene}amino)-3-phenylpropanoic acid
4-(5,7-dimethyl-4-oxo-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}deca-6,8-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
(1'r,2r,9r,9as,12'r)-15'-hydroxy-12'-methyl-2-(2-methylpropyl)-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione
2,3-dihydroxy-3,4,8,8a-tetramethyl-4-{6-oxo-2h,3h,4h-furo[2,3-c]furan-2-yl}-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl pyridine-3-carboxylate
(1r,4r,5r,8r,9s,19r)-4-[(2s)-butan-2-yl]-4,5,9-trihydroxy-9-isopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
(2s)-2-[(3-amino-6-{[(1s)-1-carboxy-2-phenylethyl]-c-hydroxycarbonimidoyl}-1-hydroxyhexylidene)amino]-3-phenylpropanoic acid
(7s,7ar)-1-({[(2r)-3-(acetyloxy)-2-hydroxy-2-[(1s)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate
4,5,9-trihydroxy-9-isopropyl-8-methyl-4-(sec-butyl)-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
15'-hydroxy-12'-methyl-2-(2-methylpropyl)-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione
(1r,4r,5s,8r,9s,19r)-4,5,9-trihydroxy-9-isopropyl-8-methyl-4-(sec-butyl)-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
8,17-dihydroxy-17-(2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl)-9-methoxy-5,12-dimethyl-2,16-dioxabicyclo[13.3.1]nonadeca-4,10-dien-3-one
C23H35NO7S (469.21341200000006)
ethyl 4-oxo-4-[(9s)-4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]butanoate
(1r,4z,8s,9s,10z,12s,15r,17r)-8,17-dihydroxy-17-[(4r)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]-9-methoxy-5,12-dimethyl-2,16-dioxabicyclo[13.3.1]nonadeca-4,10-dien-3-one
C23H35NO7S (469.21341200000006)